(Q51984878)

19 April 2018

title

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada. (English)

1 reference

19 April 2018

0 references

1 reference

O'Brien BJ

1

1 reference

19 April 2018

Goeree R

2

1 reference

19 April 2018

Hux M

3

1 reference

19 April 2018

Iskedjian M

4

1 reference

19 April 2018

Blackhouse G

5

1 reference

19 April 2018

Gagnon M

6

1 reference

19 April 2018

Gauthier S

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

19 April 2018

Journal of the American Geriatrics Society

published in

1 reference

19 April 2018

volume

47

1 reference

19 April 2018

issue

5

1 reference

19 April 2018

page(s)

570-578

1 reference

19 April 2018

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

The Mini-Mental State Examination: A Comprehensive Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

The Markov process in medical prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

The economic impact of the tacrine in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

Modelling in economic evaluation: an unavoidable fact of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02572.X

10.1111/J.1532-5415.1999.TB02572.X

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

10323651

1 reference

19 April 2018